Reaction
Product Closure Removal Difficult reporting signals
As of the last recalculation, Product Closure Removal Difficult appears in 989 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is LATANOPROST (PRR 82.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Latanoprost | 164 | 82.0 | 82.3 |
| Oxybutynin | 71 | 54.9 | 55.0 |
| Brimonidine Tartrate | 22 | 26.6 | 26.6 |
| Moxifloxacin | 15 | 22.7 | 22.8 |
| Lifitegrast | 11 | 14.3 | 14.3 |
| Minoxidil | 28 | 13.5 | 13.5 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 13.4 | 13.4 |
| Fremanezumab-Vfrm | 7 | 12.9 | 12.9 |
| Teduglutide | 8 | 12.6 | 12.6 |
| Timolol | 6 | 10.5 | 10.5 |
| Naproxen Sodium Tablet | 21 | 8.5 | 8.5 |
| Etonogestrel | 13 | 5.8 | 5.8 |